R&D
R&D | 11 September 2026

Revvity to acquire human cell design in push to advance metabolic disease drug discovery

The deal is aimed at strengthening Revvity’s capabilities in diabetes, obesity and other metabolic disease research

R&D
R&D | 06 September 2026

NBA and CSIR-IMTECH to strengthen biodiversity and microbial resource linkages

A key focus of the engagement was the regulatory framework governing microbial resources and the need to facilitate greater access to authenticated microbial type cultures for researchers and industry

R&D
R&D | 04 September 2026

CeNS researchers unlock strong piezoelectricity in peptides through molecular self-assembly

The findings could pave the way for flexible, sustainable and biocompatible energy-harvesting materials for applications including wearable electronics, implantable medical sensors, electronic skin and biosensors

R&D
R&D | 31 August 2026

Rectify unveils RTY-406 pushing new disease-modifying approach for PSC into the clinic

Rectify presented the discovery and characterization of RTY-406 during the Division of Medicinal Chemistry’s First Time Disclosures session

R&D
R&D | 31 August 2026

Bristol Myers Squibb data show sustained five-year benefits of Camzyos in obstructive HCM

Nearly all patients — 97.4% — achieved a Valsalva LVOT gradient of 30 mm Hg or less

R&D
R&D | 29 August 2026

University of Toronto researchers develop tRNA approach to target genetic diseases

Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics

R&D
R&D | 27 August 2026

Thermo Fisher launches Orbitrap Mass Spectrometers

Aims to bring molecular-level Isotope analysis to more labs

R&D
R&D | 27 August 2026

Zepbound use linked to lower healthcare costs in older adults: Lilly study

Researchers found that sustained use was associated with fewer hospital admissions and emergency department visits and lower monthly healthcare costs, excluding the cost of Zepbound itsel

R&D
R&D | 25 August 2026

Experts examine emerging evidence on how palm-derived bioactives could help address NCDs

A key focus of the Palm Conversations International India 2026 conference was the relationship between dietary fat consumption and cardiovascular health

R&D
R&D | 25 August 2026

BITS Pilani researchers develop 3D-printable hydrogel for personalised drug delivery

The pharmaceutical polymer-based hydrogel for 3D printing using extrusion-based method has the potential to be used for skin tissue engineering and customised drug delivery

R&D
R&D | 24 August 2026

AbbVie unveils new lung cancer data at 2026 WCLC

AbbVie is also advancing telisotuzumab adizutecan (Temab-A), an investigational c-Met-directed ADC carrying a topoisomerase 1 inhibitor (Top1i) payload

R&D
R&D | 24 August 2026

Chai Discovery and Bristol Myers Squibb team up to accelerate AI-driven antibody discovery

Bristol Myers Squibb will use Chai’s AI models and molecular-design platform to identify antibody candidates across its portfolio

R&D
R&D | 18 August 2026

Scientists explore electromagnetic gene switch for precise, reversible control of gene expression

The researchers identified the Lgr4 gene as particularly responsive to EMF after performing single-cell RNA sequencing of mouse brain tissue exposed to an electromagnetic field of 2.0 millitesla at 60 hertz

R&D
R&D | 17 August 2026

Godavari Biorefineries secures European patent for novel oncology formulation

The patent further strengthens company’s growing intellectual property portfolio in oncology and reflects the company’s efforts to expand its research and development capabilities beyond its traditional business areas

R&D
R&D | 14 August 2026

ICMR-SHINE 2026 brings biomedical research to school students across 83 locations

Second edition of the nationwide outreach programme opens ICMR labs to Classes 9-12 students, launches official website and announces a school competition

R&D
R&D | 12 August 2026

TIGS, BRIC-inStem renew MoU to advance genetics and genomics research

Partnership aims to accelerate translation of cutting-edge research into solutions for human health and agriculture, strengthening India’s life sciences innovation ecosystem

R&D
R&D | 11 August 2026

Novo Nordisk and AWS team up to supercharge drug discovery with Agentic AI

The companies have established a new co-innovation hub in London

R&D
R&D | 10 August 2026

Ono Pharma and Mediar Therapeutics team up to develop new antibody drugs for fibro-inflammatory diseases

Mediar will lead research and use its antibody-discovery capabilities and fibrosis-focused biology platform to identify potential drug candidates

Startup

Digitization